Health Update

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

This is not of interest to most of you, but I do get emails and queries fairly frequently, so I figure I ought to share once in a while. The big picture summary is that nothing serious is wrong; a biopsy is scheduled for Friday; and I’ve been officially enrolled in the second stage of chemo treatment (the stem cell transplant). For those who want to know more, additional detail and miscellaneous griping is below the fold.

Like I said, nothing serious is wrong. But damn. Chemotherapy has a number of bad side effects, and I mostly just accepted them while it was going on. But it’s now been nearly three weeks since chemo ended, and the side effects haven’t improved at all. In fact, they’ve gotten a little worse. The neuropathy in my feet is no better, and it’s spread a bit in the past few weeks. I feel it in my ankles, and sometimes even in my hands—which is brand new. My stomach remains mildly upset all the time, which is a good way to lose a few pounds but not good for anything else. It’s a bit more noticeable than it used to be, and I’ve even had a couple of bouts of diarrhea in the past two weeks. That’s new too. And my trouble sleeping remains unchanged. I tried tapering off my sleep meds slightly, and it just didn’t work. I gave it more than a week, but finally gave up and went back to my old dose. This used to get me about seven hours of sleep, but now it’s only good for six. That’s not horrible, but it adds up. I pretty much spend my days feeling exhausted all the time, and my emotional state is weirdly unbalanced. I periodically break out in crying jags for no apparent reason. It only lasts a minute or two, but it’s not something that’s ever happened to me before.

I have no idea if this is normal or not. I only get to see my oncologist for 20 minutes once a month, and she’s not very helpful anyway. As near as I can tell, she’s so afraid of saying or doing something she might be blamed for that she’s just not willing to say much at all. But that might be unfair. Maybe there’s just not much to say. Everyone responds differently to this stuff, and maybe there’s simply no telling how long it will take for all this stuff to clear up.

Friday’s biopsy is being done by a different oncologist, so I’ll see if I can chat with him for a few minutes before the procedure. Maybe he’ll have something useful to tell me.

None of this is horrific, and God knows I’m better off than lots of cancer patients. By relative standards, my chemo regimen was a fairly mild one. Still, expectations are everything. When chemo was over, I was looking forward to feeling better, and instead I’m feeling worse. I wish I knew what was going on. Blah.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend